Article

Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes.

Department of Pathology Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA The Royal Marsden Hospital NHS Foundation Trust, London, UK Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL, USA Counsyl, Inc., Redwood City, CA, USA.
Clinical Genetics (Impact Factor: 3.65). 07/2011; 80(1):97-8. DOI: 10.1111/j.1399-0004.2011.01691.x
Source: PubMed
0 Bookmarks
 · 
68 Views